Table 1.
Clinicopathological Characteristics of 207 HCC Patients with or without Cirrhosis
Clinicopathological characteristics | Patients(n=207) |
||
---|---|---|---|
n | % | ||
Age | ≤60 | 96 | 46.4 |
>60 | 111 | 53.6 | |
BMI | <25 | 94 | 45.4 |
≥25 | 103 | 49.8 | |
Not reported | 10 | 4.8 | |
Race | Non-Asian | 121 | 58.5 |
Asian | 80 | 38.6 | |
Not reported | 6 | 2.9 | |
AFP | ≤20ng/mL | 109 | 52.7 |
>20ng/ml | 76 | 36.7 | |
Not reported | 22 | 10.6 | |
Gender | Female | 66 | 31.9 |
Male | 141 | 68.1 | |
Hepatitis B or C | NO | 94 | 45.4 |
YES | 104 | 50.3 | |
Not reported | 9 | 4.3 | |
Alcohol consumption | NO | 148 | 71.5 |
YES | 50 | 24.2 | |
Not reported | 9 | 4.3 | |
Cirrhosis status | NO | 130 | 62.8 |
YES | 77 | 37.2 | |
Histologic grade | G1-2 | 133 | 64.2 |
G3-4 | 72 | 34.8 | |
Not reported | 2 | 1.0 | |
New tumor event | NO | 97 | 46.9 |
YES | 101 | 48.8 | |
Not reported | 9 | 4.3 | |
Pathologic stage* | Stage I+II | 155 | 74.9 |
Stage III+IV | 41 | 19.8 | |
Not reported | 11 | 5.3 | |
Cancer status | Tumor free | 116 | 56 |
With tumor | 84 | 40.6 | |
Not reported | 7 | 3.4 | |
Family cancer history | NO | 111 | 53.6 |
YES | 68 | 32.9 | |
Not reported | 28 | 13.5 | |
Residual tumor | R0 | 192 | 92.7 |
non-R0 | 13 | 6.3 | |
Not reported | 2 | 1.0 | |
Vascular invasion | Negative | 138 | 66.7 |
Positive | 60 | 29 | |
Not reported | 9 | 4.3 |
BMI, Body mass Index; AFP, Alpha fetoprotein; *TNM staging systems.